Aemetis (NASDAQ:AMTX) Receiving Somewhat Favorable News Coverage, Study Finds

Media headlines about Aemetis (NASDAQ:AMTX) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aemetis earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave press coverage about the specialty chemicals company an impact score of 45.3730963834897 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Several research firms have weighed in on AMTX. Zacks Investment Research raised Aemetis from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th. FBR & Co reiterated a “neutral” rating and issued a $2.00 target price on shares of Aemetis in a report on Saturday, August 19th.

Aemetis (AMTX) opened at 0.92 on Friday. Aemetis has a one year low of $0.78 and a one year high of $2.50. The firm’s market cap is $18.24 million. The company has a 50-day moving average price of $1.03 and a 200-day moving average price of $1.22.

COPYRIGHT VIOLATION NOTICE: “Aemetis (NASDAQ:AMTX) Receiving Somewhat Favorable News Coverage, Study Finds” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Insider Buying and Selling by Quarter for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with's FREE daily email newsletter.

Leave a Reply